CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk
      QxMD      Google Scholar   
Citation:
Nat Genet vol 54 (5) 637-648
Year:
2022
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
P30 CA021765, R35 CA197695, R01 CA178393, P30 CA044579, UG1CA189859, U10CA180820, UG1CA232760, F30CA196040; the National Institute of General Medical Sciences grant no. T32 GM080202 ; the National Library of Medicine grant no. T32 LM012416  
Corr. Author:
 
Authors:
                                                           
Networks:
 
Study
C9710
Multiple Studies, or Legacy Studies in Alliance Study:
E1900
Phases:
3, 3
Keywords: